TOPLINE:
The predictive value of the multitarget stool DNA (mt-sDNA) test is unaffected by the presence of known colorectal cancer (CRC) risk factors, suggesting it could be used in patients at increased risk for CRC.
METHODOLOGY:
- Single-center chart review of all referrals for positive mt-sDNA between 2017 and 2021.
- Calculation of diagnostic colonoscopy adherence rates.
- Comparison of detection rates for colorectal neoplasia (CRN) in patients with and without known CRC risk factors.